UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000017901
Receipt No. R000020539
Scientific Title Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the Treatment of Male Stress Urinary Incontinence
Date of disclosure of the study information 2015/07/01
Last modified on 2019/11/13 13:56:57

No. Disposal Last modified on Item of update
1 Insert 2015/06/14 17:12:04
2 Update 2015/09/02 10:51:45 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
3 Update 2015/09/02 11:10:21 Recruitment status
Anticipated trial start date
4 Update 2016/01/14 17:38:24 Key inclusion criteria
Key inclusion criteria
5 Update 2016/01/14 18:02:45 Last name of contact person
Last name of contact person
Division name
Division name
TEL
Email
6 Update 2016/05/10 15:47:09 Name of primary sponsor
Institute
Department
Organization
Organization
Category of Funding Organization
7 Update 2016/12/14 09:27:49 Key inclusion criteria
8 Update 2016/12/14 09:28:55 Last name of contact person
Last name of contact person
9 Update 2017/12/14 19:21:36 URL releasing protocol
10 Update 2018/03/28 12:02:37 Recruitment status
Last follow-up date
11 Update 2018/12/10 18:18:02 Date trial data considered complete
Date analysis concluded
12 Update 2019/06/17 09:21:55 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
TEL
Organization
Organization
Address
Address
Tel
Email
13 Update 2019/06/17 09:22:45 Number of participants that the trial has enrolled
14 Update 2019/06/17 09:24:35 Date of IRB
15 Update 2019/11/13 13:56:57 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded


Contact us.